Pulse Biosciences (NASDAQ: PLSE)
Pulse Biosciences Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Pulse Biosciences Company Info
Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.
News & Analysis
Why Pulse Biosciences Stock Moved Higher Thursday
The medical technology company got rid of $41.6 million in debt with a large private sale of stock on Thursday.
Why Alaska Air Group, Pulse Biosciences, and BJ's Restaurants Jumped Today
Learn which companies rose on better business conditions in their industry.
Valuation
Earnings Transcripts
Pulse Biosciences, Inc. (PLSE) Q3 2020 Earnings Call Transcript
PLSE earnings call for the period ending September 30, 2020.
Pulse Biosciences, Inc. (PLSE) Q2 2020 Earnings Call Transcript
PLSE earnings call for the period ending June 30, 2020.
Pulse Biosciences, Inc Common Stock (PLSE) Q1 2020 Earnings Call Transcript
PLSE earnings call for the period ending March 31, 2020.
Pulse Biosciences, Inc Common Stock (PLSE) Q4 2019 Earnings Call Transcript
PLSE earnings call for the period ending December 31, 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.